Immunization, Vaccines and Biologicals

24 July 2014

World Hepatitis Day 2014: Think again

Every year on 28 July, WHO and partners mark World Hepatitis Day to increase the awareness and understanding of viral hepatitis and the diseases that it causes.

Viral hepatitis – a group of infectious diseases known as Hepatitis A, B, C, D, and E – affects hundreds of millions of people worldwide, causing acute and chronic liver disease and killing close to 1.4 million people every year. This year, WHO and partners urge policymakers, health workers and the public to 'think again' about this silent killer.

17 July 2014

Immunization coverage reaches 84%, still short of 90% goal

More than 111 million infants received vaccines in 2013 to protect them from deadly diseases. These infants account for about 84% of the world’s children, but an estimated 21.8 million infants remained unvaccinated, according to new estimates from WHO and UNICEF.

The estimates tell a success story for the Expanded Programme on Immunization, namely that global coverage with vaccines, measured by the proportion of kids who received 3 doses of vaccines containing diphtheria tetanus-pertussis (DTP3), rose from 73% in 2000 to 84% in 2013, a substantial increase.

30 June 2014

Taking stock of immunization in South Africa

Immunization averts some 2.5 million premature deaths a year according to estimates and protects millions of children from illness and disability. Parents and children attending a South African clinic are among those today who will reap the benefits of routine immunization from the first days of life.

10 June 2014

Cost-effectiveness of HPV vaccination

Hundreds of thousands of cases of, and deaths from cervical cancer worldwide can be prevented by vaccinating 12-year old girls against the cancer-causing human papillomaviruses (HPV), according to a study published in The Lancet Global Health today. The study also showed that HPV vaccination is likely to be cost effective in almost every country in the world.

The authors of the study developed the Papillomavirus Rapid Interface for Modelling and Economics (PRIME), which is a simple analytical tool that it is straightforward enough to be used by non-experts, has fairly light data requirements and can be used and understood in different country settings.

Immunization news

fact buffet

Mortality reduction

78%drop in global measles deaths

Global control and regional elimination of measles
pdf, 916kb


84%of infants vaccinated with 3 doses of DTP vaccine in 2013

DTP3 coverage for 2013
pdf, 99kb

Incomplete vaccination

21.8 millionchildren incompletely vaccinated at 12 months of age

Data on number of unvaccinated children
pdf, 125kb